title: Letter: Vaptans for the treatment of hyponatraemia and ascites in patients with cirrhosis.
authors.forename: F
authors.initials: F
authors.lastname: Karaahmet
authors.forename: S
authors.initials: S
authors.lastname: Coban
authors.forename: O
authors.initials: O
authors.lastname: Başar
authors.forename: O
authors.initials: O
authors.lastname: Yuksel
mesh_terms: D065092:Antidiuretic Hormone Receptor Antagonists; D001201:Ascites / Q000188:drug therapy*; D001549:Benzamides / Q000627:therapeutic use*; D001552:Benzazepines / Q000627:therapeutic use*; D006801:Humans; D007010:Hyponatremia / Q000188:drug therapy*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D009025:Morpholines / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D013141:Spiro Compounds / Q000627:therapeutic use*
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D001549:Benzamides; D001552:Benzazepines; D009025:Morpholines; D011758:Pyrroles; D013141:Spiro Compounds